|
FR580494A
(fr)
|
1923-07-10 |
1924-11-07 |
Const Metalliques Schiltigheim |
Procédé d'établissement des buses d'aération ou autres tuyaux
|
|
US2837464A
(en)
|
1955-01-11 |
1958-06-03 |
Schering Corp |
Process for production of dienes by corynebacteria
|
|
DE1059906B
(de)
|
1954-10-05 |
1959-06-25 |
Scherico Ltd |
Verfahren zur Herstellung von 1, 4-Pregnadienen
|
|
US3067197A
(en)
|
1961-04-26 |
1962-12-04 |
Pfizer & Co C |
11-oxygenated 6alpha-fluoro-16-methylene-delta-pregnenes and derivatives
|
|
GB1047518A
(en)
|
1963-06-11 |
1966-11-02 |
Glaxo Lab Ltd |
17ª-monoesters of 11,17,21-trihydroxy steroid compounds
|
|
GB1158492A
(en)
|
1966-02-09 |
1969-07-16 |
Boots Pure Drug Co Ltd |
Improvements in Acylated Steroids
|
|
US3639434A
(en)
|
1967-02-02 |
1972-02-01 |
Boots Pure Drug Co Ltd |
17-acyloxysteroids and their manufacture
|
|
IT1061787B
(it)
|
1967-03-01 |
1983-04-30 |
Vismara Francesco Spa |
Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
|
|
GB1227992A
(enExample)
|
1968-01-23 |
1971-04-15 |
Koninklijke Gist Spiritus |
|
|
IT1034011B
(it)
|
1969-06-26 |
1979-09-10 |
Vister Vismara Terapeutici S P |
Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato
|
|
GB1384372A
(en)
|
1971-01-20 |
1975-02-19 |
Glaxo Lab Ltd |
Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
|
|
US3828080A
(en)
|
1972-01-20 |
1974-08-06 |
Glaxo Lab Ltd |
Androstane-17beta-carboxylic acids and processes for the preparation thereof
|
|
US3989686A
(en)
|
1972-06-15 |
1976-11-02 |
Glaxo Laboratories Limited |
Anaesthetic steroids of the androstane series and process for preparing same
|
|
GB1438940A
(en)
|
1972-07-19 |
1976-06-09 |
Glaxo Lab Ltd |
17beta-haloalkoxycarbonyl-17alpha-oxysteroids
|
|
GB1440063A
(en)
|
1972-08-11 |
1976-06-23 |
Glaxo Lab Ltd |
17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids
|
|
DE2336693A1
(de)
|
1973-07-19 |
1975-02-06 |
Nassheuer Ind Ofenbau Jean |
Strahlheizrohr
|
|
GB1517278A
(en)
|
1974-08-30 |
1978-07-12 |
Glaxo Lab Ltd |
Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates
|
|
US4093721A
(en)
|
1974-08-30 |
1978-06-06 |
Glaxo Laboratories Limited |
Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
|
|
YU54476A
(en)
|
1975-03-31 |
1982-05-31 |
Taisho Pharmaceutical Co Ltd |
Process for obtaining 17-ester 21-halo-pregnane
|
|
DE2538569A1
(de)
|
1975-08-29 |
1977-03-03 |
Siemens Ag |
Verfahren zur metallisierung von duroplasten
|
|
CH628355A5
(de)
|
1976-02-24 |
1982-02-26 |
Ciba Geigy Ag |
Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
|
|
US4221787A
(en)
|
1978-03-28 |
1980-09-09 |
Interx Research Corporation |
Esteramide prodrugs of anti-inflammatory corticosteroids
|
|
US4187301A
(en)
|
1978-04-05 |
1980-02-05 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
|
|
US4261984A
(en)
|
1978-04-05 |
1981-04-14 |
Syntex (U.S.A.) Inc. |
17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
|
|
US4188385A
(en)
|
1978-04-05 |
1980-02-12 |
Syntex (U.S.A.) Inc. |
Thioetianic acid derivatives
|
|
US4263289A
(en)
|
1978-04-05 |
1981-04-21 |
Syntex (U.S.A.) Inc. |
Thio etianic acid derivatives
|
|
US4198403A
(en)
|
1978-04-05 |
1980-04-15 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes
|
|
DE2817988A1
(de)
|
1978-04-25 |
1979-11-08 |
Hoechst Ag |
Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
|
|
US4310466A
(en)
|
1979-08-31 |
1982-01-12 |
Syntex (U.S.A.) Inc. |
Thio etianic acid derivatives
|
|
US4267173A
(en)
|
1979-11-05 |
1981-05-12 |
Schering Corporation |
Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
|
|
GB2088877B
(en)
|
1980-02-15 |
1984-07-04 |
Glaxo Group Ltd |
Androstane 17 carbothioates
|
|
US4335121A
(en)
|
1980-02-15 |
1982-06-15 |
Glaxo Group Limited |
Androstane carbothioates
|
|
US4996335A
(en)
|
1980-07-10 |
1991-02-26 |
Nicholas S. Bodor |
Soft steroids having anti-inflammatory activity
|
|
SE449106B
(sv)
|
1980-07-10 |
1987-04-06 |
Otsuka Pharma Co Ltd |
Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
|
|
US4710495A
(en)
|
1980-07-10 |
1987-12-01 |
Otsuka Pharmaceutical Co., Ltd. |
Soft steroids having anti-inflammatory activity
|
|
ZA814440B
(en)
|
1980-07-10 |
1982-10-27 |
Otsuka Pharma Co Ltd |
Soft steroids having anti-inflammatory activity
|
|
EP0057401B1
(en)
|
1981-02-02 |
1984-08-01 |
Schering Corporation |
Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
|
|
ZW6584A1
(en)
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
|
US4607028A
(en)
|
1983-08-18 |
1986-08-19 |
Ciba-Geigy Corporation |
Novel carboxylic acid esters
|
|
EP0179583A1
(en)
|
1984-10-04 |
1986-04-30 |
Merck & Co. Inc. |
A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
|
|
US4861765A
(en)
|
1985-06-26 |
1989-08-29 |
Jouveinal |
21-alkyl-, cycloalkyl- or aryl-substituted thio steroids and pharmaceutical compositions containing them
|
|
ZA872389B
(en)
|
1987-04-02 |
1987-11-25 |
Advanced Polymer Systems Inc |
Composition and method for delivering a steroid active ingredient
|
|
WO1989003390A1
(en)
|
1987-10-13 |
1989-04-20 |
Bodor Nicholas S |
Soft steroids having anti-inflammatory activity
|
|
US4994439A
(en)
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
|
US5202316A
(en)
|
1989-03-22 |
1993-04-13 |
Roussel Uclaf |
N,N,N',N'-6-(1-piperazinyl)-2,5-pyridinediamines
|
|
FR2644788B1
(fr)
|
1989-03-22 |
1995-02-03 |
Roussel Uclaf |
Nouveaux steroides 3-ceto comportant une chaine en 17 amino-substituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
|
|
JPH07116215B2
(ja)
|
1989-04-19 |
1995-12-13 |
エスエス製薬株式会社 |
新規なステロイド化合物
|
|
EP0477195A1
(en)
|
1989-06-16 |
1992-04-01 |
The Upjohn Company |
Suramin type compounds and angiostatic steroids to inhibit angiogenesis
|
|
IL95590A
(en)
|
1989-09-08 |
1996-06-18 |
Glaxo Group Ltd |
Medicinal preparations containing Salmetrol and Pluticasone Propionate
|
|
DE3931041C2
(de)
|
1989-09-16 |
2000-04-06 |
Boehringer Ingelheim Kg |
Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
|
DE4025342A1
(de)
|
1990-08-10 |
1992-02-13 |
Hoechst Ag |
In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
|
|
JP3087763B2
(ja)
|
1990-11-30 |
2000-09-11 |
三井化学株式会社 |
新規な複素環式化合物およびそれを含有する医薬組成物
|
|
GB9103764D0
(en)
|
1991-02-22 |
1991-04-10 |
Glaxo Group Ltd |
Compositions
|
|
US5250293A
(en)
|
1991-04-22 |
1993-10-05 |
Gleich Gerald J |
Method for the treatment of hypersensitivity diseases by administration of anionic polymers
|
|
TW247878B
(enExample)
|
1991-07-02 |
1995-05-21 |
Takeda Pharm Industry Co Ltd |
|
|
US6127353A
(en)
|
1991-09-06 |
2000-10-03 |
Schering Corporation |
Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
|
|
US5658549A
(en)
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
|
DE69413955T2
(de)
|
1993-03-17 |
1999-04-01 |
Minnesota Mining And Mfg. Co., Saint Paul, Minn. |
Aerosolzusammensetzung enthaltend einen aus ester-, amid- oder merkaptoester- derivat dispergiermittel
|
|
DE4328819A1
(de)
|
1993-08-27 |
1995-03-02 |
Hoechst Ag |
Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
|
DE4333920A1
(de)
|
1993-10-05 |
1995-04-13 |
Hoechst Ag |
Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
|
US5420120A
(en)
|
1993-12-17 |
1995-05-30 |
Alcon Laboratories, Inc. |
Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
|
|
US5837699A
(en)
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
|
IL109656A
(en)
|
1994-05-15 |
1998-02-22 |
Chemagis Ltd |
Process for the manufacture of androstane - 17 - carbothioates and androstane - 17 - carbothioates prepared thereby
|
|
GB9410222D0
(en)
|
1994-05-21 |
1994-07-06 |
Glaxo Wellcome Australia Ltd |
Medicaments
|
|
GB9419536D0
(en)
|
1994-09-28 |
1994-11-16 |
Glaxo Inc |
Medicaments
|
|
AR002009A1
(es)
|
1994-12-22 |
1998-01-07 |
Astra Ab |
Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
|
|
JPH08291072A
(ja)
|
1995-04-22 |
1996-11-05 |
Kissei Pharmaceut Co Ltd |
吸入用粉末製剤用結晶とその製造方法
|
|
JPH08291073A
(ja)
|
1995-04-22 |
1996-11-05 |
Kissei Pharmaceut Co Ltd |
医薬品組成物及びその製造方法
|
|
DE19528145A1
(de)
|
1995-08-01 |
1997-02-06 |
Boehringer Ingelheim Kg |
Neue Arzneimittel und ihre Verwendung
|
|
GB9521696D0
(en)
|
1995-10-23 |
1996-01-03 |
Bayer Ag |
Combination of LTD4 receptor antagonists with glucocorticosteriods
|
|
US5707984A
(en)
|
1995-12-08 |
1998-01-13 |
G. D. Searle & Co. |
Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
|
|
US5792758A
(en)
|
1995-12-08 |
1998-08-11 |
G. D. Searle & Co. |
Steroid nitrite ester derivatives useful as anti-inflammatory drugs
|
|
KR19990076859A
(ko)
|
1995-12-29 |
1999-10-25 |
그레이엄 브레레톤, 레슬리 에드워즈 |
17.베타.-카르복시, 카르보티오 및 아미드 안드로스탄 유도체의락톤 유도체
|
|
US5985862A
(en)
|
1996-05-02 |
1999-11-16 |
G.D. Searle & Co. |
Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
|
|
US5981517A
(en)
|
1996-05-09 |
1999-11-09 |
Soft Drugs, Inc. |
Androstene derivatives
|
|
AU3153797A
(en)
|
1996-06-04 |
1998-01-05 |
Procter & Gamble Company, The |
A nasal spray containing an intranasal steroid and an antihistamine
|
|
GB9622173D0
(en)
|
1996-10-24 |
1996-12-18 |
Glaxo Group Ltd |
Particulate Products
|
|
US5919776A
(en)
|
1996-12-20 |
1999-07-06 |
Merck & Co., Inc. |
Substituted aminoquinolines as modulators of chemokine receptor activity
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
WO1998043630A1
(en)
|
1997-04-02 |
1998-10-08 |
Brigham And Women's Hospital, Inc. |
Means of ascertaining an individual's risk profile for atherosclerotic disease
|
|
ATE260931T1
(de)
|
1997-06-30 |
2004-03-15 |
Glaxo Group Ltd |
Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
|
|
SE9704186D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
|
SE9704833D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New formulation
|
|
US5972920A
(en)
|
1998-02-12 |
1999-10-26 |
Dermalogix Partners, Inc. |
Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
|
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
|
US6136294C1
(en)
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
|
US6261539B1
(en)
|
1998-12-10 |
2001-07-17 |
Akwete Adjei |
Medicinal aerosol formulation
|
|
GB9828721D0
(en)
|
1998-12-24 |
1999-02-17 |
Glaxo Group Ltd |
Novel apparatus and process
|
|
AU3703900A
(en)
|
1999-02-24 |
2000-09-14 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
|
AU3411000A
(en)
|
1999-03-24 |
2000-10-09 |
Glenayre Electronics, Inc |
Computation and quantization of voiced excitation pulse shapes in linear predictive coding of speech
|
|
AU776608B2
(en)
|
1999-04-30 |
2004-09-16 |
Pfizer Products Inc. |
Glucocorticoid receptor modulators
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
US20020081266A1
(en)
|
1999-08-20 |
2002-06-27 |
Norton Healthcare Ltd. |
Spray dried powders for pulmonary or nasal administration
|
|
AU782386C
(en)
|
1999-08-31 |
2006-08-10 |
Brigham And Women's Hospital |
Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases
|
|
DE60034954D1
(de)
|
1999-09-14 |
2007-07-05 |
Xenoport Inc |
Substrate und screeningverfahren für transportproteine
|
|
US6596261B1
(en)
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
|
JP2004501067A
(ja)
|
2000-01-28 |
2004-01-15 |
ローム アンド ハース カンパニー |
高められた特性をもつ医薬
|
|
US20020133032A1
(en)
|
2000-02-25 |
2002-09-19 |
Jufang Barkalow |
Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
|
|
GB0009583D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory formulations
|
|
GB0009591D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Medical combinations
|
|
GB0009592D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory combinations
|
|
GB0009606D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Therapeutic combinations
|
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
|
GB0016040D0
(en)
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
GB0017988D0
(en)
|
2000-07-21 |
2000-09-13 |
Glaxo Group Ltd |
Novel process
|
|
JP2004504357A
(ja)
|
2000-07-26 |
2004-02-12 |
アルコン，インコーポレイテッド |
ポリマー性懸濁化剤を含有しない薬学的懸濁組成物
|
|
KR100331704B1
(ko)
|
2000-07-31 |
2002-04-09 |
윤길림 |
인터넷을 이용한 프로그램 임대시스템
|
|
US6858596B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
|
US6777400B2
(en)
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6787532B2
(en)
|
2000-08-05 |
2004-09-07 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivatives
|
|
CZ304043B6
(cs)
|
2000-08-05 |
2013-09-04 |
Glaxo Group Limited |
Estery steroidních thiokyselin
|
|
US6777399B2
(en)
*
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6858593B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
|
US6750210B2
(en)
|
2000-08-05 |
2004-06-15 |
Smithkline Beecham Corporation |
Formulation containing novel anti-inflammatory androstane derivative
|
|
AR032362A1
(es)
|
2000-08-14 |
2003-11-05 |
Glaxo Group Ltd |
Formulacion topica estable de una emulsion de aceite en agua y proceso para su preparacion
|
|
HUP0303107A2
(hu)
|
2000-09-29 |
2004-03-01 |
Glaxo Group Ltd. |
Gyulladásos betegségek kezelésére alkalmazható vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
|
|
AU2002210575A1
(en)
|
2000-10-31 |
2002-05-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Novel medicament compositions based on anticholinergics and corticosteroids
|
|
TWI290145B
(en)
|
2000-12-22 |
2007-11-21 |
Nippon Shinyaku Co Ltd |
Preventives/remedies for inflammatory airway diseases
|
|
US20020132803A1
(en)
|
2001-01-05 |
2002-09-19 |
Mahendra Dedhiya |
Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
ATE365720T1
(de)
|
2001-03-08 |
2007-07-15 |
Glaxo Group Ltd |
Agonisten von beta-adrenorezeptoren
|
|
WO2002076933A1
(en)
|
2001-03-22 |
2002-10-03 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
|
UA77656C2
(en)
|
2001-04-07 |
2007-01-15 |
Glaxo Group Ltd |
S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
|
|
US20050070487A1
(en)
|
2001-04-24 |
2005-03-31 |
Nyce Jonathan W. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
|
US7291608B2
(en)
|
2001-04-30 |
2007-11-06 |
Glaxo Group Limited |
Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
|
|
DE10130371A1
(de)
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
|
|
US20030018019A1
(en)
|
2001-06-23 |
2003-01-23 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
|
|
WO2003013427A2
(en)
|
2001-08-03 |
2003-02-20 |
Smithkline Beecham Corporation |
A method for preparing fluticasone derivatives
|
|
GB0124523D0
(en)
|
2001-10-12 |
2001-12-05 |
Glaxo Group Ltd |
Pharmaceutical combination
|
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
|
CN1613012A
(zh)
|
2001-11-05 |
2005-05-04 |
布赖汉姆妇女医院 |
可溶的cd40l(cd154)作为动脉粥样硬化的疾病的先兆标记
|
|
GB0127160D0
(en)
|
2001-11-12 |
2002-01-02 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2003042229A1
(en)
|
2001-11-12 |
2003-05-22 |
Glaxo Group Limited |
Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids
|
|
WO2003048181A1
(en)
|
2001-12-01 |
2003-06-12 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
|
WO2003072592A1
(en)
|
2002-01-15 |
2003-09-04 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
|
AU2003201693A1
(en)
|
2002-01-21 |
2003-09-02 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
|
JP3691459B2
(ja)
|
2002-06-14 |
2005-09-07 |
久光メディカル株式会社 |
粉末状吸入剤組成物
|
|
GB0217504D0
(en)
|
2002-07-29 |
2002-09-04 |
Novartis Ag |
Organic compounds
|
|
US7244742B2
(en)
|
2002-08-17 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
|